Cytosorbents Corporation (CTSO)
Market Closed
10 Sep, 20:00
$
6. 37
+0.04
+0.6319%
Pre Market
$
+0.63 +9.8901% 7. 00
21.52M Market Cap
- P/E Ratio
- Div Yield
14,387 Volume
- Eps
$ 6.33
Previous Close Investors:
Want to track CTSO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cytosorbents Corporation (CTSO) Statistics
Valuation metrics
Market Cap 21.52M
Enterprise value 43.92M
Trailing P/E (ttm) -1.22
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 0.59
Price/Book (mrq) -29.28
Enterprise Value/Revenue 1.18
Enterprise Value/EBITDA -3.11
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 232.6K
Average volume (90 days) 140.6K
Price summary
52-Week low 6
52-Week high 20.4
Beta -
50-Day moving average 0.37
200-Day moving average 0.58
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 8 Sep 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.49%
Operating margin -0.33%
Operational effectiveness
Return on assets -0.48%
Return on equity -4.45%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.59
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.29
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.07
Total debt (mrq) -
Total Debt/Equity (mrq) -35.07
Current ratio (mrq) 0.66%
Book value per share (mrq) -0.01
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
